For Emerging Companies

Biotech & Startups

Move from concept to credible data faster — without hiring a full discovery team.

Your challenges

Limited Discovery Headcount

A founding thesis but limited internal headcount to execute discovery work.

Investor Data Requirements

Investors expecting a preclinical data package before the next round.

Patent Documentation

A computational pipeline that needs documentation to support patent counsel before partnership talks.

Asset Validation

An asset (compound, target, biomarker) needing validation before licensing.

Regulatory Navigation

A regulatory pathway you have not navigated, with no in-house regulatory lead.

How Science Habitat helps

Senior PhD-level scientific judgement applied where in-house capacity is thin.

PhD-Level Scientific Judgement

Science Habitat works alongside you with senior PhD-level scientific judgement applied where in-house capacity is thin.

NDA Protection

NDAs are signed before substantive scoping.

Full Ownership

You own the deliverables.

Milestone-Driven Process

Engagements are scoped, tracked, and delivered against written milestones.

What we deliver

AI/ML drug-discovery support: target identification, in silico screening, mechanistic modelling. Multi-omics analytics for preclinical asset development. Precision genome-editing design (CRISPR/Cas9 guide design, off-target prediction, validation strategy). Investor-grade scientific decks and pre-IND / IND writing support. Scientific documentation that supports patent counsel (Human Inventive Contribution records).

Ready to advance your research?

From hypothesis to peer-review — let's scope a tailored plan for your lab.

NDA protected · You own 100% of deliverables · Milestone-based